Oral therapy for Peyronie's disease

被引:0
|
作者
L A Mynderse
M Monga
机构
[1] Mayo Clinic,Department of Urology
[2] University of Minnesota,Department of Urologic Surgery
来源
International Journal of Impotence Research | 2002年 / 14卷
关键词
Peyronie's disease; oral therapy; vitamin E; Potaba; Colchicine; Tamoxifen;
D O I
暂无
中图分类号
学科分类号
摘要
Peyronie's disease (PD) remains a therapeutic dilemma for the urologist. Despite a myriad of medical therapies proposed for PD there have been limited advances in oral medical treatment. Several new approaches are presented which hold promise of success, although a definitive medical therapy for PD has yet to be established. Since early stage disease is reputed to respond better than well-established plaques, an early trial of inexpensive, safe and well-tolerated oral therapy is often initially recommended. This review discusses the historical aspects as well as contemporary oral medical therapy for PD. With advances in the molecular biology of inflammation and wound healing, the management and understanding of this frustrating disease will no doubt improve.
引用
收藏
页码:340 / 344
页数:4
相关论文
共 50 条
  • [31] Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study
    Favilla, V.
    Russo, G. I.
    Privitera, S.
    Castelli, T.
    Madonia, M.
    La Vignera, S.
    Condorelli, R.
    Calogero, A. E.
    Farina, F. P.
    Cimino, S.
    Morgia, G.
    ANDROLOGIA, 2014, 46 (08) : 936 - 942
  • [32] Extracorporeal shockwave therapy for Peyronie's disease: An alternative treatment?
    Poulakis, V
    Skriapas, K
    de Vries, R
    Dillenburg, W
    Ferakis, N
    Witzsch, U
    Melekos, M
    Becht, E
    ASIAN JOURNAL OF ANDROLOGY, 2006, 8 (03) : 361 - 366
  • [33] Advances in stem cell therapy for the treatment of Peyronie's disease
    Moussa, Mohamad
    Abou Chakra, Mohamad
    Moussa, Yasmin
    INTRACTABLE & RARE DISEASES RESEARCH, 2020, 9 (01) : 10 - 13
  • [34] Update on Medical Management of Peyronie's Disease
    Tan, Ronny B. W.
    Sangkum, Premsant
    Mitchell, Gregory C.
    Hellstrom, Wayne J. G.
    CURRENT UROLOGY REPORTS, 2014, 15 (06)
  • [35] Treatment of Peyronie's disease with oral colchicine: long‐term results and predictive parameters of successful outcome
    A Kadioğlu
    A Tefekli
    T Köksal
    M Usta
    H Erol
    International Journal of Impotence Research, 2000, 12 : 169 - 175
  • [36] Noninvasive Treatment Options for Peyronie's Disease
    Ory, Jesse
    MacDonald, Landan
    Langille, Gavin
    SEXUAL MEDICINE REVIEWS, 2020, 8 (04) : 603 - 614
  • [37] Review of Management Options for Active-Phase Peyronie's Disease
    Brimley, Scott C.
    Yafi, Faysal A.
    Greenberg, Jacob
    Hellstrom, Wayne J. G.
    Hoang Minh Tue Nguyen
    Hatzichristodoulou, Georgios
    SEXUAL MEDICINE REVIEWS, 2019, 7 (02) : 329 - 337
  • [38] Peyronie's disease: epidemiology, diagnosis, and management
    Miner, Martin M.
    Seftel, Allen D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (01) : 113 - 120
  • [39] Peyronie's disease: an update of the medical management
    Maan, Z
    Arya, M
    Shergill, I
    Joseph, JV
    Patel, HRH
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (04) : 799 - 805
  • [40] Combination of Penile Traction, Intralesional Verapamil, and Oral Therapies for Peyronie's Disease
    Abern, Michael R.
    Larsen, Stephen
    Levine, Laurence A.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 (01) : 288 - 295